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IntroductIon
Psychiatry, in terms of neuropsychiatry, 
has experienced an impressive revival in 
the field of neurology over the past two 
decades. This especially holds true for epi-
leptology (Reynolds and Trimble, 2009). 
A large number of studies have addressed 
depressive and other affective disorders in 
patients with seizures. Depression is now 
widely acknowledged as a frequent psy-
chiatric comorbidity of seizure disorders 
(Barry et al., 2008; LaFrance et al., 2008).
Here we critically explore the concept 
of depression as a comorbidity in epilepsy 
(see also Hoppe and Elger, 2011). First, we 
address criteria which differentiate between 
transiently altered mood states and psychi-
atric mood disorders. We then show that 
depression in epilepsy provides a perfect 
model for the biopsychosocial etiology of 
depression and discuss related therapeutic 
approaches. Finally, we provide some gen-
eral remarks on what is required to main-
tain or restitute emotional well-being in 
patients with therapy–refractory epilepsy.
defInIng depressIon comorbIdIty
In this section, we make suggestions in order 
to clarify the concept of depression as a psy-
chiatric comorbidity in epilepsy.
mood regulatIon dIsorder
Evidently, depressive mood per se is not 
sufficient for diagnosing a psychiatric dis-
order (Mula et al., 2008; Holtzheimer and 
Mayberg, 2011). For example, feeling blue is 
the adequate affective response to suffering 
(e.g., bereavement). Unfortunately, epilepsy 
and other severe chronic conditions provide 
too many opportunities to reasonably feel 
bad. So what distinguishes a mood disorder 
from altered but still normal mood?
We suggest defining affective disorders 
as disorders of mood regulation rather than 
alterations of mood state (Holtzheimer and 
Mayberg, 2011; Hoppe and Elger, 2011). 
This proposal clarifies established diagnos-
tic criteria. For example, “loss of pleasure” 
is a key symptom of depressive disorders 
(DSM-IV–TR, ICD-10) and signifies the 
absence of formerly shown positive affec-
tive responses to still pleasurable stimuli 
(i.e., altered mood regulation resulting in 
an inadequate affective response).
In otherwise healthy people, a sustained 
depressive mood lasting more than 2 weeks 
or so is probably inadequate (except in cases 
of bereavement or other similarly traumatic 
life events) and may therefore reasonably 
serve as a reliable indicator of mood dys-
regulation. However, in patients with severe 
chronic diseases such as epilepsy, things may 
look quite different. For these patients, the 
diagnostic focus should be set more explic-
itly on mood dysregulation – that is, on the 
inadequacy of the affective response with 
regard to the current life conditions and the 
patient’s personality. Adjusting neuropsy-
chiatric evaluation tools to the conditions of 
a chronic disease might alter the prevalence 
estimates of psychiatric disorders (Jones 
et al., 2010).
multI-dImensIonal dIsorder
Depressive mood comprises vegetative 
symptoms (chronic fatigue, sleep disor-
ders, anergia, reduced libido, and elevated 
stress); affective symptoms (feeling blue, 
loss of pleasure, ill temper, and irritability); 
behavioral changes (withdrawal from social 
and other activities, passive avoidance, help-
lessness); and cognitive alterations (rumi-
nation, hopelessness, loss of self-esteem, 
or feelings of guilt). Our clinical experi-
ence shows that the composition of these 
dimensions of depression differs between 
patients with epilepsy versus those without 
epilepsy. Depressive mood alterations in 
epilepsy patients often remain subsyndro-
mic if the established psychiatric criteria of 
major depression are applied (Kanner et al., 
2010a). In depressed epilepsy patients, the 
somatic and behavioral alterations appear 
more dominant than cognitive alterations. 
However, vegetative and affective symp-
toms might have been caused by the antie-
pileptic medication, and the behavior may 
have changed in an attempt to cope with 
the threat of seizures (e.g., self-protection 
or avoidance of embarrassing situations). 
This demonstrates that it is essential to take 
epilepsy-related factors into account when 
conducting a neuropsychiatric evaluation 
of mood states (for a different view, see 
Krishnamoorthy et al., 2007).
epIlepsy as an etIologIcal model 
for depressIon
We assume that mental states (such as 
moods) are emergent properties of the 
material organism, especially the brain, 
which implies strong psychophysiological 
correlations but non-identity and irreduc-
ibility of both aspects. In keeping with this 
non-reductionist approach, epilepsy pro-
vides intriguing examples for both a com-
plex psychosocial etiology of depression 
and for the role of intrinsic neuroetiologi-
cal factors.
stress
Within the framework of the diathesis–
stress model (Monroe and Simons, 1991), 
depression is viewed as the result of over-
whelming life challenges (i.e., stress) in 
combination with an individual diathesis 
(i.e., a disadvantageous organic or psy-
chological disposition or vulnerability). 
More precisely, stress represents a psycho-
physiological reaction and results from an 
actual or perceived discrepancy between life 
demands and available coping resources. 
This concept was also addressed as allostatic 
load (McEwen, 1998).
Evidently, epilepsy and non-epileptic sei-
zure disorders represent a condition with 
unusual and heavy life demands. The burden 
of epilepsy may comprise seizure-related 
injuries and hospitalizations, cognitive and 
behavioral impairments, restricted mobil-
ity, reduced educational outcomes, lower 
socioeconomic and marital status, and – 
humiliatingly – social stigma (de Boer et al., 
2008). The role of seizure-related stress for 
depression etiology is highlighted by the fact 
that the depression prevalence in patients 
with non-epileptic seizures (LaFrance and 
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parents caring for a child with epilepsy (Lv 
et al., 2009) is the same as that for patients 
with active epilepsy.
learned helplessness
Learned helplessness is still the most influ-
ential paradigm for inducing depression-
like behaviors in experimental animals 
(Duman, 2010). Procedures like the forced 
swim test comprise repeated and uncon-
trollable aversive, usually life-threatening 
stimulation. Evidently, this is the exact 
type of experience for patients suffering 
from seizures, regardless of whether they 
are epileptic or non-epileptic (Hermann 
et al., 1996). Cognitively, helplessness 
translates into increased external locus 
of control attributions and loss of the 
sense of internal control. Several studies 
confirmed causal attribution style altera-
tions in epilepsy patients (McLaughlin 
et al., 2010).
loss of reInforcement
The intrinsic inability to experience pleas-
ure could be correlated with alterations of 
the mesocorticolimbic dopamine system, 
i.e., the brain’s reward system (Stone et al., 
2008; Martin-Soelch, 2009). However, 
experiences of social stigmatization or 
embarrassing situations related to seizures 
(e.g., enuresis) may reasonably result in 
epilepsy patients withdrawing from rein-
forcing social activities. In addition, the 
patient may have been advised to forego 
specific activities as they are associated with 
unacceptable health risks if seizures should 
occur (e.g., swimming). As a result, patients 
lose pleasant physical and social activities 
and this has a strong negative effect on their 
well-being.
perI-Ictal depressIon
Depressive mood alterations have been 
reported not only as a frequent precipitant 
of seizures (Spector et al., 2000), but also 
as a symptom of prolonged (lasting over 
2–3 days) postictal recovery (Kanner et al., 
2010b). Of note, postictal depression with 
acute suicidal urge has been documented 
in a single case (Fincham and Anderson, 
2000). For those patients who experi-
ence several seizures per month, it appears 
pointless to distinguish interictal from 
peri-ictal depression (Mula et al., 2010). 
Electropathophysiological alterations  similar 
to epileptogenic abnormalities have also been 
stated for non-epileptic patients with major 
depression (Shelley et al., 2008).
IatrogenIc depressIon
Depression is an important side-effect 
of phenobarbital (Brent et al., 1987) and 
primidone (Lopez-Gomez et al., 2005). 
Psychiatric adverse effects comprising 
irritability and aggressiveness have been 
reported for levetiracetam (Mula et al., 
2003). The FDA issued a black box warn-
ing which listed an increased suicidality risk 
for all antiepileptic drugs (Hesdorffer and 
Kanner, 2009), although this is still being 
debated.
treatIng depressIon In epIlepsy
The highly debated issue of antidepressant 
drugs versus psychotherapy for depres-
sion treatment is an empirical question 
of finding the safest, most effective, and 
most efficient way of normalizing mood 
regulation (i.e., restituting the ability to 
experience adequate affective response). In 
general, most experts agree with us that far 
more interventional therapeutic studies are 
required (Kanner, 2003).
antIdepressant drugs
Drug treatment for depression is not about 
(unethically and illegally) inducing states of 
happiness (or inhibiting negative feelings). 
Instead, and more ambitiously, medical 
drug treatment should aim at the restitu-
tion of normal mood regulation, i.e., the 
ability to experience adequate positive and 
negative affective response (Holtzheimer 
and Mayberg, 2011). However, no sub-
stantial improvement of depression treat-
ment could be achieved during the last 
50–70 years (Holtzheimer and Mayberg, 
2011). According to recent meta-analyses 
(Ioannidis, 2008; Turner et al., 2008), sero-
tonin reuptake inhibitors (SSRIs) showed 
only moderate therapeutic efficacy and 
then only for severe depression (which is 
less prevalent in epilepsy). The expanding 
use of antidepressants in the US over the last 
three decades has had no obvious effect on 
the suicide rates (Hu et al., 2008).
Expert recommendations for using 
SSRIs for treatment of depression in epi-
lepsy (Barry et al., 2008) are based on a 
surprisingly sparse empirical basis (Mula 
and Schmitz, 2009; Hoppe and Elger, 2011). 
No controlled studies on currently available 
antidepressants have been performed in epi-
lepsy patients. Single-arm studies indicated 
mood improvements, but also frequent 
adverse effects and relatively low therapy 
adherence. In many studies on epilepsy, 
patients using antidepressants continue to 
show elevated scores for depressive mood.
psychotherapy
Although a publication bias must also be 
considered for studies on psychotherapy of 
depression (Cuijpers et al., 2010), a mod-
erate efficacy has been adequately shown 
for cognitive-behavioral therapy (CBT; 
DeRubeis et al., 2008), acceptance and 
commitment therapy (Lundgren et al., 
2008), and behavioral activation therapy 
(Lundgren et al., 2008; Sturmey, 2009). CBT 
also showed efficacy in depressed patients 
with somatic chronic conditions (Beltman 
et al., 2010), including epilepsy. One study 
demonstrated the potential for preventing 
depression in adolescents with new-onset 
epilepsy (Martinovic et al., 2006). Currently, 
several clinical programs are set-up which 
explore different ways of offering psycho-
therapeutic support to epilepsy patients, 
including the use of web-based technolo-
gies (Thompson et al., 2010).
non-medIcal professIonal support
According to our reading of the diathesis–
stress model, stress occurs as a result of both 
objective life demands and disadvantageous 
personal disposition. Consequently, patient 
support should also address real life condi-
tions, which is beyond the scope of medical 
health care professionals. Rehabilitative care 
programs and counseling by social workers 
and psychologists may contribute toward 
improving the familial situation, personal 
relationships, job or educational affairs, and 
leisure activities – all of which is promis-
ing to decrease stress (Ridsdale, 2009). In 
addition, psychological training (apart from 
therapy) may improve the coping skills as 
well as the compensation of cognitive defi-
cits affecting daily life.
conclusIon: emotIonal well-
beIng In epIlepsy
The challenge of supporting patients with 
epilepsy is enabling them to maintain or 
restitute their emotional well-being and 
life satisfaction when dealing with sei-
zures which are, as of yet, untreatable. This 
requires a complex adaptation of attitudes 
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lies toward actively coping with the given 
situation; adequate use of medical and non-
medical support; strengthening resilience; 
and maintaining (or restituting) pleasant 
activities. Many patients will find their way 
with support of their families and friends 
while others rely on their doctor’s advice, 
psychotherapy, or patient groups.
Antiepileptic drug treatment eventually 
must be reconsidered with regard to pos-
sible psychiatric side effects and possible 
seizure-related impairments of mood regu-
lation. Even if more evidence is required 
for the efficacy and safety of antidepres-
sive drugs, experts consistently recommend 
their use in depressed epilepsy patients 
based on clinical experience. In general, 
drugs might contribute to but will probably 
not replace the difficult process of adjust-
ing the conduct of life to the conditions of 
active epilepsy.
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